Msd Partners, L.P. Synthetic Biologics, Inc. Transaction History

Msd Partners, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Jun 22, 2023	SELL	$2.3 - $4.3 $535,578 - $1 Million	-232,860 Reduced 66.67%	116,430 $337,000
Q4 2021 Jun 22, 2023	BUY	$2.7 - $4.5 $628,722 - $1.05 Million	232,860 Added 200.0%	349,290 $943,000
Q2 2021 Jun 22, 2023	BUY	$4.6 - $7.2 $535,578 - $838,296	116,430 New	116,430 $698,000
Q2 2021 Aug 16, 2021	SELL	$4.6 - $7.2 $3.88 Million - $6.08 Million	-844,250 Reduced 87.88%	116,430 $70,000
Q1 2021 May 17, 2021	BUY	$5.0 - $11.7 $4.8 Million - $11.2 Million	960,680 New	960,680 $655,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Msd Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Msd Partners, L.P. with notifications on news.